Remarkably, IGF2BP2 regulates glutamine uptake and metabolism by upregulating MYC, glutamic–pyruvic transaminase 2 (GPT2), and solute carrier family 1 member 5 (SLC1A5) in AML, demonstrating that IGF2BP2s can influence amino acid metabolism in cancer [99]. Here, MYC is linked to cancer.